13,139 resources
Start Prev Rows 7400 - 7600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.520.4.14 | NAACCR Behavior Code | active | 2010-01 | oid | |||
| hl7.fhir.us.carin-bb | R4 | NCPDPRejectCode | NCPDP Reject Code Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.carin-bb | R4 | NCPDPPrescriptionOriginCode | NCPDP Prescription Origin Code Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.carin-bb | R4 | NCPDPDispensedAsWrittenOrProductSelectionCode | NCPDP Dispense As Written (DAW)/Product Selection Code Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.carin-bb | R4 | NCPDPCompoundCode | NCPDP Compound Code Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.core | R4 | us-core-problem-or-health-concern | US Core Problem or Health Concern | trial-use | 3 | cgp | 2022-09 | hl7 | fhir tho |
| hl7.fhir.us.breastcancer | R3 | shr-core-YesNoUnknownVS | BC YesNoUnknownVS ValueSet | draft | 2018-08 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.1066 | Healthcare Provider Taxonomy | active | 2024-06 | hl7 | nucc | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.520.4.5 | NAACCR TNM Edition Number | active | 2010-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) | active | 2017-01 | sct loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.9 | Type of Recreational Drug (HL7) | active | 2020-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) | active | 2017-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) | active | 2017-01 | sct | |||
| hl7.fhir.us.vrdr | R4 | vrdr-place-of-death-vs | Place of Death ValueSet | active | pher | 2024-10 | hl7 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative | active | 2017-01 | sct tho | |||
| hl7.fhir.us.davinci-ra | R4 | coding-gap-remark | Coding Gap Remark | trial-use | 2 | cqi | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) | active | 2014-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) | active | 2014-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) | active | 2014-01 | sct | |||
| hl7.fhir.us.davinci-pct | R4 | PCTContributorTaskStatusCodes | Provider GFE Contributor Task Status Codes | trial-use | fm | 2025-08 | hl7 | fhir | |
| hl7.fhir.us.davinci-pct | R4 | PCTCoordinationTaskStatusCodes | GFE Coordination Task Status Codes | trial-use | fm | 2025-08 | hl7 | fhir | |
| hl7.fhir.us.davinci-crd | R4 | cardActions | CDS Hooks Card Suggestion Action Types Value Set | trial-use | 4 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.dental-data-exchange | R4 | dental-procedure-codes-vs | Dental Procedure Codes Value Set | draft | 2025-04 | hl7 | |||
| hl7.fhir.us.davinci-crd | R4 | billingCodes | CRD Billing Codes Value Set | trial-use | 4 | fm | 2025-08 | hl7 | cpt rx cms |
| fhir.outburn.co.il | R4 | diagnostic-procedures | diagnostic procedures during pregnencies codes | draft | hl7 | sct | |||
| fhir.outburn.co.il | R4 | amniotic-fluid-index | Codes for Amniotic Fluid Index | draft | hl7 | sct | |||
| hl7.fhir.us.davinci-dtr | R4 | questionnaireAudience | Audience Value Set | trial-use | 1 | cds | 2025-08 | hl7 | fhir |
| hl7.fhir.us.davinci-crd | R4 | AdditionalDocumentation | CRD Coverage Information Additional Documentation Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.davinci-crd | R4 | informationNeeded | CRD Information Needed Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir tho |
| hl7.fhir.us.davinci-crd | R4 | coveragePaDetail | CRD Coverage Information Prior Authorization Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.davinci-crd | R4 | coverageInfo | CRD Coverage Information Covered Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.11 | eICR Initiation | active | 2019-01 | oid | |||
| hl7.fhir.us.davinci-pcde | R4 | PCDEPlanAction | PCDE Plan Action | draft | 2022-08 | hl7 | cpt oid ndc | ||
| hl7.fhir.us.davinci-pcde | R4 | PCDEPlanActionReason | PCDE Plan Action Reason | draft | 2022-08 | hl7 | icd | ||
| hl7.fhir.us.mcode | R4 | mcode-radiotherapy-treatment-location-vs | Radiotherapy Treatment Location Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-cancer-body-location-vs | Cancer Body Location Value Set | active | 4 | cic | 2025-02 | hl7 | sct tho |
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.80 | Pregnancy Status Determination Method | active | 2024-06 | hl7 | sct | ||
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-modality-vs | Brachytherapy Modality Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-radiotherapy-modality-vs | Radiotherapy Modality Value Set | active | 3 | cic | 2025-02 | hl7 | fhir tho |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-modality-vs | Teleradiotherapy Modality Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.davinci-dtr | R4 | informationOrigins | Information Origins Value Set | trial-use | 2 | cds | 2025-08 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-technique-vs | Brachytherapy Technique Value Set | active | 3 | cic | 2025-02 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-radiotherapy-technique-vs | Radiotherapy Technique Value Set | active | 3 | cic | 2025-02 | hl7 | fhir tho |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-technique-vs | Teleradiotherapy Technique Value Set | active | 3 | cic | 2025-02 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-radiotherapy-volume-type-vs | Radiotherapy Volume Type Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.pacio-rt | R4 | timepoint-entity-type-vs | Timepoint Entity Type Value Set | active | 2022-10 | hl7 | fhir | ||
| hl7.fhir.us.identity-matching | R4 | Identity-Identifier-vs | Identity Identifier Value Set | trial-use | 2 | pa | 2025-08 | hl7 | fhir |
| hl7.fhir.us.physical-activity | R4 | pa-condition-verification-status | PA Condition Verification Status | trial-use | 2 | pc | 2024-03 | hl7 | tho |
| hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-status | PA DiagnosticReport Statuses | trial-use | 2 | pc | 2024-03 | hl7 | fhir |
| hl7.fhir.us.ndh | R4 | HealthcareServiceEligibilityCodeVS | Healthcare Service Eligibility Code Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.directory-query | R4 | IdentifierStatusVS | Identifier Status Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.ndh | R4 | IdentifierStatusVS | Identifier Status Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.ndh | R4 | BenefitTypeVS | Benefit Type Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.ndh | R4 | NDHCareTeamCategoryVS | NDH Care Team Category Value Set | trial-use | pa | 2025-07 | hl7 | loinc | |
| hl7.fhir.us.ndh | R4 | NdhEndpointEnvironmentVS | NDH Endpoint Environment Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.physical-activity | R4 | pa-observation-status | PA Observation Statuses | trial-use | 2 | pc | 2024-03 | hl7 | fhir |
| hl7.fhir.us.physical-activity | R4 | pa-observation-code-evs | PA Observation Vital Sign Codes | trial-use | 2 | pc | 2024-03 | hl7 | loinc |
| hl7.fhir.us.physical-activity | R4 | pa-servicerequest-intent | PA ServiceRequest Intents | trial-use | 2 | pc | 2024-03 | hl7 | fhir |
| fhir.giis | R4 | AEFISeverityVS | Adverse Event severity codes | draft | 2025-07 | hl7 | internal | ||
| fhir.giis | R4 | AEFINameVS | Adverse Event codes | draft | 2025-07 | hl7 | internal | ||
| acme.base.r4 | R4 | birthsex | Birth Sex | active | 2022-06 | tho | |||
| signal.core.r4 | R4 | birthsex | Birth Sex | active | 2022-09 | hl7 | vsac | ||
| hl7.fhir.us.davinci-pct | R4 | PCTTaskBusinessStatusCodes | PCT GFE Request Task Business Status ValueSet | trial-use | fm | 2025-08 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | EndpointAccessControlMechanismVS | Endpoint Access Control Mechanism Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | AgeGroupVS | Age Range Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.directory-query | R4 | EndpointUsecaseVS | Endpoint Usecases Value Set | active | 2022-12 | hl7 | tho | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointUsecaseVS | Endpoint Usecases VS | trial-use | fm | 2025-02 | hl7 | tho | |
| hl7.fhir.us.ndh | R4 | NdhDirectTrustEndpointUsecaseVS | NDH Direct Trust Endpoint Usecase Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | NdhFhirEndpointUseCaseVS | NDH FHIR Endpoint Usecase Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.directory-query | R4 | DeliveryMethodVS | Delivery Methods Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | DeliveryMethodVS | Delivery Methods VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | EmploymentStatusVS | Employment Status Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.ndh | R4 | AccessibilityVS | Accessibility Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.directory-query | R4 | AccessibilityVS | Accessibility Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | AccessibilityVS | Accessibility VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | InsuranceStatusVS | Insurance Status Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.directory-query | R4 | LanguageProficiencyVS | Language Proficiency Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | LanguageProficiencyVS | Language Proficiency VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | EndpointTestingMethodVS | Endpoint Testing Method Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | TrustProfileVS | Trust Profile Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | VerificationProcessVS | NDH Verification Process Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.icsr-ae-reporting | R4 | ICSRSectionCodeVS | ICSR Section Codes Value Set | draft | 2023-08 | hl7 | fhir | ||
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationDerivedFromIdType | SDOHCC ValueSet Observation DerivedFrom IdType | trial-use | 2 | pc | 2025-05 | hl7 | tho |
| hl7.fhir.us.davinci-crd | R4 | coverageDetail | CRD Coverage Detail Codes Value Set | trial-use | 4 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.davinci-crd | R4 | deviceRequest | CRD Device Request Codes Value Set | trial-use | 4 | fm | 2025-08 | hl7 | cpt cms |
| hl7.fhir.us.physical-activity | R4 | pa-observation-code-time | PA Observation Time-related codes | trial-use | 2 | pc | 2024-03 | hl7 | loinc |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7910 | Regional Labs (ARLN) | active | 2019-01 | oid | |||
| hl7.fhir.us.ndh | R4 | DigitalcertificateUseVS | Digital Certificate Use Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.davinci-pct | R4 | PCTGFERequestTypeVS | PCT GFE Request Type Codes ValueSet | trial-use | fm | 2025-08 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | PractitionerRoleVS | PractitionerRole Code Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.directory-query | R4 | PractitionerRoleVS | PractitionerRole Code Value Set | active | 2022-12 | hl7 | fhir tho | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | PractitionerRoleVS | PractitionerRole Code VS | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.davinci-pct | R4 | PCTOrgContactPurposeTypeVS | PCT Organization Contact Purpose Value Set | trial-use | fm | 2025-08 | hl7 | fhir tho | |
| hl7.fhir.us.pacio-cs | R4 | pacio-cat-vs | PACIO Functioning Category Value Set | active | 2024-11 | hl7 | fhir | ||
| hl7.fhir.us.pacio-fs | R4 | pacio-cat-vs | PACIO Functioning Category Value Set | active | 2021-11 | hl7 | fhir | ||
| hl7.fhir.us.pacio-rt | R4 | timepoint-class-vs | Timepoint Class Value Set | active | 2022-10 | hl7 | fhir tho | ||
| hl7.fhir.us.pacio-rt | R4 | timepoint-status-vs | Timepoint Status Value Set | active | 2022-10 | hl7 | fhir | ||
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetOMBEthnicityCategories | SDOHCC ValueSet OMB Ethnicity Categories | trial-use | 2 | pc | 2025-05 | hl7 | oid |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetOMBRaceCategories | SDOHCC ValueSet OMB Race Categories | trial-use | 2 | pc | 2025-05 | hl7 | oid |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskCode | SDOHCC ValueSet Task Code | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value | trial-use | 2 | pc | 2025-05 | hl7 | tho loinc |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskPriority | SDOHCC ValueSet Task Priority | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationDataAbsentReason | SDOHCC ValueSet Observation DataAbsentReason | trial-use | 2 | pc | 2025-05 | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7915 | Carbapenemase phenotypic result (ARLN) | active | 2019-01 | sct | |||
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetReferralTaskStatus | SDOHCC ValueSet Referral Task Status | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetObservationStatus | SDOHCC ValueSet Observation Status | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetTaskStatus | SDOHCC ValueSet Task Status | trial-use | 2 | pc | 2025-05 | hl7 | fhir |
| hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-type | PA DiagnosticReport Types | trial-use | 2 | pc | 2024-03 | hl7 | fhir loinc |
| hl7.fhir.us.physical-activity | R4 | pa-servicerequest-code | PA ServiceRequest Intervention Codes | trial-use | 2 | pc | 2024-03 | hl7 | sct |
| hl7.fhir.us.directory-query | R4 | ConsentVS | National Directory Consent Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.directory-attestation | R4 | ConsentVS | NatDir Consent Scopes Valueset | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.ndh | R4 | NdhVerificationStatusVS | NDH Verification Status Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| hl7.fhir.us.directory-query | R4 | VirtualModalitiesVS | Virtual Modalities Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | VirtualModalitiesVS | Virtual Modalities VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.spl | R5 | valueset-splColor | SPL Color | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splComboProductType | SPL Combo Product Type | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splDoseForm | SPL Dose Form | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splFlavor | SPL Flavor | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splMarketingCategories | SPL Marketing Categories | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splOperationType | SPL Operation Type | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splPackageTypes | SPL Package Types | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splRouteOfAdministration | SPL Route of Administration | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splShape | SPL Shape | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-splSpecialMeasures | SPL Special Measures | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.davinci-crd | R4 | cdsHookType | CDS Hook Types Value Set | trial-use | 4 | fm | 2025-08 | hl7 | fhir |
| signal.core.r4 | R4 | chargeitem-status | ChargeItemStatus | trial-use | 0 | pa | 2019-10 | hl7 | fhir |
| signal.core.r4 | R4 | invoice-status | InvoiceStatus | trial-use | 0 | fm | 2019-10 | hl7 | fhir |
| signal.core.r4 | R4 | event-status | EventStatus | trial-use | 3 | fhir | 2019-10 | hl7 | fhir |
| signal.core.r4 | R4 | request-status | RequestStatus | draft | 3 | pc | 2019-10 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-myeloma-iss-stage-value-vs | International Staging System (ISS) for Myeloma Stage Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-myeloma-riss-stage-value-vs | Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-all-risk-assessment-value-vs | Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-binet-stage-value-vs | Binet Stage Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-neuroblastoma-INRGSS-value-vs | International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-pretext-stage-value-vs | PRETEXT Stage Value | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-rai-stage-value-vs | Rai Stage Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set | active | cic | 2025-02 | hl7 | ncit sct | |
| hl7.fhir.us.mcode | R4 | mcode-international-retinoblastoma-stage-value-vs | International Retinoblastoma Stage Value | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.pacio-adi | R4 | ADIPMOConsentCategoriesVS | Portable Medical Order Categories | trial-use | 2 | pe | 2025-08 | hl7 | tho |
| hl7.fhir.us.pacio-adi | R4 | ADIAttesterRoleTypeVS | Attester Role | trial-use | 2 | pe | 2025-08 | hl7 | loinc |
| hl7.fhir.us.physical-activity | R4 | pa-task-status | PA Task Fulfillment Status | trial-use | 2 | pc | 2024-03 | hl7 | fhir |
| hl7.fhir.us.pacio-adi | R4 | ADIHCADecisionsVS | Healthcare Agent Decisions | trial-use | 2 | pe | 2025-08 | hl7 | fhir loinc |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) | active | 2008-01 | sct tho oid | |||
| hl7.fhir.us.davinci-pct | R4 | PCTAdjustmentReasonVS | PCT Adjustment Reason | trial-use | fm | 2025-08 | hl7 | x12 | |
| hl7.fhir.us.illTraveler | R4 | InfectiousDiseaseVS | Infectious Disease VS | draft | 2024-03 | hl7 | sct | ||
| signal.core.r4 | R4 | request-intent | RequestIntent | draft | 3 | oo | 2019-10 | hl7 | fhir |
| signal.core.r4 | R4 | invoice-priceComponentType | InvoicePriceComponentType | trial-use | 0 | fm | 2019-10 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set | active | cic | 2025-02 | hl7 | sct | |
| fhir.paciosampledata | R4 | MAPProblemPriorityVS | Medical Action Plan Problem Priority | draft | 2025-07 | hl7 | sct tho | ||
| hl7.fhir.us.mcode | R4 | mcode-deauville-scale-vs | Deauville Scale Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.physical-activity | R4 | pa-observation-code-activity | PA Observation Activity-related codes | trial-use | 2 | pc | 2024-03 | hl7 | fhir loinc |
| hl7.fhir.us.core | R4 | us-core-observation-smoking-status-status | US Core Status for Smoking Status Observation | trial-use | 3 | cgp | 2022-09 | hl7 | fhir |
| signal.core.r4 | R4 | observation-status | ObservationStatus | normative | 5 | oo | 2019-10 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.828 | Country | active | 2018-01 | iso tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.829 | County | active | 2019-01 | tho oid | |||
| hl7.fhir.us.mcode | R4 | mcode-tumor-marker-test-vs | Tumor Marker Test Value Set | active | 1 | cic | 2025-02 | hl7 | loinc |
| hl7.fhir.us.mcode | R4 | mcode-histology-morphology-behavior-vs | Histology Morphology Behavior Value Set | active | 4 | cic | 2025-02 | hl7 | sct tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7897 | Lab Test Measurement (CO) | active | 2019-01 | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3025 | Case Confirmation Method | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative | active | 2008-01 | sct | |||
| fhir.cdc.opioid-cds-r4 | R4 | office-visit | Office Visit | active | 2023-05 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3048 | Lab Test Interpretation | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3027 | Case Transmission Mode | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3026 | Case Detection Method | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) | active | 2008-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3046 | Specimen Reshipment Reason | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3035 | Reason For Test (Hepatitis) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3047 | Specimen Shipped | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3044 | Microbiology strain | active | 2008-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) | active | 2008-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) | active | 2008-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3036 | Reporting Source Type | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) | active | 2013-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) | active | 2008-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3031 | Incarceration Type (Hepatitis) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3030 | Disease Acquired Jurisdiction | active | 2014-01 | tho oid | |||
| hl7.fhir.us.spl | R5 | valueset-registrantOrganizationTypes | Registrant Organization Types | trial-use | 1 | brr | 2025-07 | hl7 | fhir |
| hl7.fhir.us.davinci-crd | R4 | coverageDetailCategories | CRD Coverage Detail Categories Value Set | trial-use | 1 | fm | 2025-08 | hl7 | fhir |
| hl7.fhir.us.breastcancer | R3 | cimi-element-AnatomicalLocationVS | BC AnatomicalLocationVS ValueSet | draft | 2018-08 | hl7 | sct | ||
| hl7.fhir.us.davinci-ra | R4 | confidence-scale | RA Confidence Scale | trial-use | 2 | cqi | 2025-07 | hl7 | sct |
| hl7.fhir.us.spl | R5 | valueset-gdufaFacilityBusinessOperationQualifiers | GDUFA Facility Business Operation Qualifiers | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-businessOperationQualifiers | Business Operation Qualifiers | trial-use | 1 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.spl | R5 | valueset-topLevelOrganizationTypes | Top-Level Organization Types | trial-use | 1 | brr | 2025-07 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-risk-assessment-type-vs | Risk Assessment Type Value Set | active | cic | 2025-02 | hl7 | ncit | |
| hl7.fhir.us.mcode | R4 | mcode-cancer-stage-type-vs | Cancer Stage Type Value Set | active | 4 | cic | 2025-02 | hl7 | ncit sct |
| hl7.fhir.us.spl | R5 | valueset-SubmittedMedicinalProductCharacteristicCodes | SPL Product Characteristic Types ValueSet | trial-use | 1 | brr | 2025-07 | hl7 | fhir |
| hl7.fhir.us.davinci-ra | R4 | hierarchical-status | Hierarchical Status | trial-use | 2 | cqi | 2025-07 | hl7 | fhir |
| hl7.fhir.us.davinci-pr | R4 | RemittanceContentType | Remittance Advice Content Type Value Set | trial-use | 1 | claims | 2025-04 | hl7 | ietf |
| hl7.fhir.us.davinci-pr | R4 | RemittanceAdviceType | Remittance Advice Value Set | trial-use | 1 | claims | 2025-04 | hl7 | ietf |
FHIR